Clinical trial

Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer

NCT00003855 · Alliance for Clinical Trials in Oncology, Other · Completed

Key facts

NCT number NCT00003855
Title Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
Official title A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Lead sponsor Alliance for Clinical Trials in Oncology, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Breast Cancer
Intervention type Procedure, Radiation
Interventions axillary lymph node dissection, whole breast irradiation
Enrollment 605
Start date Apr 1, 1999
Primary completion Aug 1, 2007
Completion Feb 1, 2011
First posted Jan 27, 2003
Last update posted Apr 29, 2020
Countries Australia, Canada, Ireland, United States

At a glance

  • 100–999 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies